NZ517552A - Process for preparing methylene bisphosphonic and salts - Google Patents

Process for preparing methylene bisphosphonic and salts

Info

Publication number
NZ517552A
NZ517552A NZ517552A NZ51755200A NZ517552A NZ 517552 A NZ517552 A NZ 517552A NZ 517552 A NZ517552 A NZ 517552A NZ 51755200 A NZ51755200 A NZ 51755200A NZ 517552 A NZ517552 A NZ 517552A
Authority
NZ
New Zealand
Prior art keywords
salt
acid
bisphosphonic acid
butanol
dichloromethylene
Prior art date
Application number
NZ517552A
Inventor
Mark Purdie
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SE9903345A priority Critical patent/SE9903345D0/en
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Priority to PCT/GB2000/003473 priority patent/WO2001021629A1/en
Publication of NZ517552A publication Critical patent/NZ517552A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3856Polyphosphonic acids containing halogen or nitro(so) substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3843Polyphosphonic acids containing no further substituents than -PO3H2 groups

Abstract

Salts of a methylene bisphosphonic acid of formula (I), and a process for preparing salts of a methylene bisphosphonic acid of formula (I) (wherein X is independently hydrogen or halogen) comprising hydrolyzing an ester of formula (II) using hydrochloric acid of concentration 15-20% by weight, and converting the acid to a salt using a base.

Description

<div class="application article clearfix" id="description"> <p class="printTableText" lang="en">New Zealand Paient Spedficaiion for Paient Number 517552 <br><br> 51755? <br><br> WO 01/21629 PCT/GBOO/03473 <br><br> PROCESS FOR PREPARING METHYLENE BIOSPHOSPHONIC AND SALTS. <br><br> The present invention relates to an improved process for the preparation of salts, in particular amine salts and sodium salts of methylene bisphosphonic acids of formula I <br><br> , ^ X\ .P-OH <br><br> , W/® <br><br> x2^;p-oh v (I) <br><br> wherein X1 and X2 are independently hydrogen or halogen. The invention also relates to the salts of methylene bisphosphonic acids of formula I. These salts are useful in the 10 preparation of the compounds described in EP0683789. <br><br> Previously known processes for preparing bisphosphonic acids involved hydrolysing the corresponding tetraesters using strong acids, such as halogen acids. Thus, for example, the isopropyl tetraester has been boiled for several hours with concentrated hydrochloric acid. <br><br> is The publication Houben-Weyl, Methoden der Organischen Chemie, XII, 1, 352-356 describes the hydrolysis of tetraesters with half-concentrated hydrochloric acid under elevated pressure and at 130-145°C. The disadvantage of these processes is the impurities in the products and the numerous purification steps needed to remove by-products and .. excess acid. . <br><br> 20 <br><br> EP 0200980 describes a process in which methylene bisphosphonic acids were prepared by hydrolysing tetraesters with water, by boiling at reflux temperature of the reaction mixture. Whilst problems of impurities of corrosion were largely overcome, the reaction time was very long, as long as 16 hours, which is disadvantageous for commercial production. <br><br> The hydrolysis of the tetraester disclosed in W091/03480 is performed using from 1.0 to 5% by weight hydrochloric acid. Active charcoal is required to decolourise the solution. <br><br> WO 01/21629 <br><br> PCT/GB0O/O3473 <br><br> 2 <br><br> GB 1026366 describes the preparation of the tetrasodium salt of dichloromethylenebisphosphonic acid by refluxing dichloromethvlene bisphosphonate tetraisopropyl ester with concentrated hydrochloric acid. The acidic solution was concentrated and twice azeotroped with isopropanol. Neutralisation of the acid with sodium hydroxide yielded the tetrasodium salt. <br><br> It has now been found that the salt formed from the acid which in turn is formed by hydrolysing a substituted or unsubstituted ester of methylene bisphosphonic acid with 15 to 20% by weight hydrochloric acid, followed by the azeotropic removal of water using n-butanol. can be easily isolated in a good yield and has far fewer impurities <br><br> According to a first aspect of the invention there is provided a process for preparing salts of substituted or unsubstituted methylene bisphosphonic acids of general formula I, <br><br> wherein X1 and X2 are independently hydrogen or halogen, which process comprises hydrolysing, using hydrochloric acid, the corresponding ester of formula II, <br><br> X &gt;H <br><br> X: &gt;H <br><br> O <br><br> (II) <br><br> wherein X1 and X2 are defined above and R is a CM straight or branched alkyl group and converting the acid to a salt by reaction with a base characterised in that the concentration <br><br> WO 01/21629 <br><br> PCT/GBOO/03473 <br><br> n <br><br> J <br><br> of hydrochloric acid is from 15% to 20% by weight, and water is removed azeotropically from the resultant acid using n-butanol prior to the addition of an amine or a base. <br><br> 1 ^ <br><br> Preferably X and X" are both fluorine, chlorine or bromine. <br><br> Most preferably X1 and X2 are both chlorine. <br><br> The tetraester of formula II is preferably the isopropyl ester such as dichloromethylene bisphosphonate tetraisopropyl ester. <br><br> The acid product of the hydrolysis may be reacted with an organic or inorganic base such as a C,.6 straight or branched primary, secondary or tertiary alkylamine, aralkyl amine, basic N-containing heterocycle, alkali or alkaline earth metal hydroxides. <br><br> The preferred bases are Cj_4 straight or branched and primary, secondary or tertiary alkyl amines, aralkyl amines, basic N-containing heterocycle. or alkali metal hydroxides. <br><br> Suitable bases may be selected from the group comprising triethylamine, tri-n-propylamine. diisopropylethylamine, tri-n-butylamine, pyridine, tribenzylamine and sodium hydroxide. <br><br> The volume of hydrochloric acid used is from 3 to 5 volumes and the hydrolysis using the acid is preferably carried out at a temperature of about 80°C to about 90°C. Following the addition of n-butanol a vacuum is suitably applied. <br><br> Thus in a preferred process according to the invention an ester of methylenebisphosphonic acid, such as dichloromethylene bisphosphonate tetraisopropyl ester, is dissolved in from about 15% to about 20% hydrochloric acid, preferably about 18% hydrochloric acid. The resultant solution is added dropwise to a stirred solution of 15% to 18% hydrochloric acid which has been heated to a temperature of from about 80°C to about 90°C, preferably <br><br> WO 01/21629 <br><br> 4 <br><br> PCT/GB00/03473 <br><br> about 85°C. The total volume of acid used is in the range of from about 3 to about 5 volumes, preferably about 4 volumes. The solution is then stirred at the elevated temperature for from about 1 to about 3 hours, preferably about 2 hours, under a flow of nitrogen, whilst collecting the distillate. After this time the solution is heated to get a steady flow of distillate. Further water is added to the hot reaction mixture and then further solvent removed by distillation. <br><br> The reaction mixture is then cooled prior to the addition of n-butanol. Vacuum and heat are then applied to the vessel. Distillate is removed whilst periodically adding n-butanol. An n-butanol solution of the dichloromethylene bisphosphonic acid is then obtained. The solution may then be diluted with n-butanol and another alcohol if desired. To this solution is added the amine or base and the reaction mixture is stirred. For the mono(tri-n-butvlamine) salt crystallisation typically begins within 30 minutes, while many others precipitate more rapidly. The suspension is then filtered and the solid washed with n-butanol. The damp solid is dried in vacuo to give the dichloromethylene bisphosphonic acid salt in high yield. <br><br> Use of hydrochloric acid within the defined range of concentration in the process of the invention has the advantage that the hydrolysis can be completed within 2 hours. No analytical methodj&amp;xequired to follow the reaction and no purification, with for example charcoal, is required. <br><br> The azeotropic removal of water using n-butanol results in a far superior removal of water than isopropanol. It also has the advantage of producing the end product in better yields as small amounts of water can have a significant effect on the crystallisation of the salt. <br><br> The use of vacuum lowers the azeotropic boiling point for water/n-butanol mixtures. The amount of water removed is also increased which reduces processing time. Thus the use of vacuum speeds up the removal of water and the control of temperature limits impurity formation. <br><br> WO 01/21629 <br><br> 5 <br><br> PCT/GB00/03473 <br><br> According to a second aspect of the invention there is provided a salt of a substituted or <br><br> I n unsubstituted methylene bisphosphonic acid of formula I wherein X and X" are <br><br> 1 <br><br> independently hydrogen or halogen. Preferably X and X" are both hydrogen, fluorine, <br><br> 1 I <br><br> chlorine or bromine, most preferably X and X" are both chlorine. Alternatively, one of X and X" is hydrogen and one is chlorine. <br><br> The salt may be a C]_6 straight or branched primary, secondary or tertiary alkvl amine salt, an aralkyl amine salt, a basic N-containing heterocycle salt, an alkali or alkaline earth metal salt. <br><br> Preferably the salt is a CM straight or branched primary, secondary or tertiary alkylamine salt, an aralkyl amine salt, a basic N-containing heterocycle salt or an alkali metal salt such as sodium or potassium salt. <br><br> Most preferably the salt is a triethylamine, tri-n-propylamine, diisopropylethylamine, tri-n-butylamine, pyridine, tribenzylamine or sodium salt. The sodium salt may be the di-, tri- or tetra§Gdium salt. . <br><br> The process of the invention will be described in more detail by way of reference to the following non-limiting examples: - <br><br> Example 1 <br><br> Preparation of dichloromethylene bisphosphonic acid, mono(tri-n-butylamine) salt <br><br> Dichloromethylene bisphosphonate tetraisopropyl ester (10 g. 0.024 mole) was dissolved in 18% hydrochloric acid (30 ml). The resultant solution was added dropwise to a stirred heated (85°C) solution of 18% hydrochloric acid (10ml). The solution was then stirred at 85°C for 2 hours under a flow of nitrogen whilst collecting the distillate (isopropyl <br><br> WO 01/21629 <br><br> 6 <br><br> PCT/GB0O/O3473 <br><br> chloride). After this time the temperature was raised and the acid distilled off until the minimum volume was reached (15 ml for this experiment). Put and take with water was done keeping the volume as low as possible (13 x 3 ml portion). The reaction mixture was then cooled prior to the addition of n-butanol (20 ml). Vacuum was applied to the vessel and the temperature raised to remove the water/n-butanol, keeping the temperature below 100°C. Solvent was again removed until the minimum volume was reached. This was repeated by the addition of two further portions of n-butanol (20 ml). The solution was then diluted with n-butanol to give the product in a total volume of 41 ml. To this solution was added ethanol (9 ml) to give the product at a concentration of 6 ml/g in 15% ethanol/n-butanol. The reaction mixture was then treated with tri-n-butylamine (1.0 equiv.). The reaction mixture was stirred overnight. The suspension was then filtered and the solid washed with n-butanol (3 ml). The damp solid was dried in vacuo at 80°C overnight to give dichloromethylene bisphosphonic acid, mono(tri-n-butylamine) salt as a white solid in excellent yield (9.27 g, 89%). <br><br> H N <br><br> 7.26 3.26 <br><br> 7,38 - 3^24" — <br><br> Example2 ....... . <br><br> Preparation of dichloromethylene bisphosphonic acid, monopyridine salt <br><br> To 15.3 ml of an n-butanol solution of dichloromethylene bisphosphonic acid prepared as in Example 1 was added industrial methylated spirits (IMS) (2.7 ml) and the solution was stirred for 5 minutes before the addition of pyridine (0.59 ml, l.Oeq) which caused instant precipitation. The resultant slurry was stirred overnight. The solid was filtered off and washed with a small amount of n-butanol. The damp solid (2.27g) was dried in vacuo overnight at 80°C. This gave the monopyridine salt (2.07 g, 88%). <br><br> Elemental Analysis C H N <br><br> Elemental Analysis C <br><br> Calc. % 36.29 <br><br> Found % 36.43 <br><br> WO 01/21629 <br><br> PCT/GB0Q/03473 <br><br> 7 <br><br> Calc. %: <br><br> 22.24 <br><br> 2.80 <br><br> 4.32 <br><br> H,0. 0.00% <br><br> Found %: <br><br> 22.07 <br><br> 2.85 <br><br> 4.19 <br><br> Example 3 <br><br> Preparation of dichloromethylene bisphosphonic acid, mono(triethylamine) salt <br><br> To 15.3 ml of an n-butanol solution of dichloromethylene bisphosphonic acid prepared as in Example 1 was added n-butanol (2.7 ml) and the solution was stirred for 5 minutes before the addition of triethylamine (1.01 ml. 1 .Oeq) which caused instant precipitation. The resultant slurry was stirred overnight. The solid was filtered off and washed with a small amount of n-butanol. The damp solid (2.3 8g) was dried in vacuo overnight at 80°C. This gave the mono(triethylamine) salt (2.28 », 91%). <br><br> Elemental Analysis C H N <br><br> Calc. %: 24.29 5.53 4.05 H20,0.00% <br><br> Found %: 24.32 5.53 3.82 <br><br> Example 4 <br><br> Preparation of dichloromethylene bisphosphonic acid, mono(diisopropvlethvjamine) . salt ■ T <br><br> To 15.3 ml of an n-butanol solution of dichloromethylene bisphosphonic acid prepared as in Example 1 was added IMS (2.7 ml) and the solution was stirred for 5 minutes before the addition of diisopropylethylamine (1.27 ml, l.Oeq) which caused instant precipitation. The resultant slurry was stirred overnight. The solid was filtered off and washed with a small amount of n-butanol. The damp solid (2.59g) was dried in vacuo overnight at 80°C. This gave the mono(diisopropylethylamine) salt (2.47g 91%). <br><br> Elemental Analysis C H N <br><br> WO 01/21629 <br><br> PCT/GB00/03473 <br><br> 8 <br><br> Calc. %: 28.29 6.20 3.74 H20.0.00% <br><br> Found %: 28.64 6.13 3.92 <br><br> Example 5 <br><br> Preparation of dichloromethylene bisphosphonic acid, mono(tribenzylamine) salt <br><br> To 15.3 ml of an n-butanol solution of dichloromethylene bisphosphonic acid prepared as in Example 1 was added n-butanol (2.7 ml) and the solution was stirred for 5 minutes before the addition of tribenzylamine (2.09 g, 1 .Oeq). The resultant slurry was stirred overnight. The solid was filtered off and washed with a small amount of n-butanol. The damp solid (4.35g) was dried in vacuo overnight at 80°C. This gave the mono(tribenzylamine) salt (3.54 g, 92%). <br><br> Elemental Analysis <br><br> C <br><br> H <br><br> N <br><br> Calc. %: <br><br> 49.64 <br><br> 4.73 <br><br> 2.63 <br><br> H2Or 0.00% <br><br> Found %: <br><br> 49.61 <br><br> 4.71 <br><br> 2.59 <br><br> Example 6 <br><br> Preparation of dichloromethylene bisphosphonic acid, monoftn-n-nropvlamine) salt <br><br> To 15.3 ml of an n-butanol solution of dichloromethylene bisphosphonic acid prepared as in Example 1 was added n-butanol (2.7 ml) and the solution was stirred for 5 minutes before the addition of tri-n-propylamine (1.38 ml, 1 .Oeq) which caused instant precipitation. The resultant slurry was stirred overnight. The solid was filtered off and washed with a small amount of n-butanol. The damp solid (3.28g) was dried in vacuo overnight at 80°C. This gave the mono(tri-n-propvlamine) salt (2.50 g, 89%). <br><br> Elemental Analysis C H N <br><br> Calc. %: 30.94 6.49 3.61 H:0,0.00% <br><br></p> </div>

Claims (1)

    <div class="application article clearfix printTableText" id="claims"> <p lang="en"> WO 01/21629<br><br> 9<br><br> PCT/GB00/03473<br><br> Found %: 31.14 6.56 3.37<br><br> Example 7<br><br> Preparation of dichloromethylene bisphosphonic acid, disodium salt<br><br> To 15.3 ml of an n-butanol solution of dichloromethylene bisphosphonic acid prepared as in Example 1 was added a solution of sodium hydroxide (0.58 g, 2 equiv.) in water (1 ml) which caused instant precipitation. The resultant slurry was stirred overnight. The solid was filtered off and washed with a small amount of n-butanol. The damp solid (2.94g) was dried in vacuo overnight at 80°C. This gave the disodium salt (1.82 g, 87%).<br><br> Elemental Analysis Calc. %:<br><br> Found %:<br><br> C<br><br> 4.16 3.99<br><br> H<br><br> 0.70 0.90<br><br> H20, 0.00%<br><br> WO 01/21629<br><br> 10<br><br> PCT/GB00/03473<br><br> CLAIMS:<br><br> 1. A process for preparing salts of a substituted or unsubstituted methylene bisphosphonic acid of general formula I<br><br> °- OH<br><br> W<br><br> /<br><br> X-\.P-OH<br><br> x2";p-oh<br><br> O \&gt;H<br><br> (I)<br><br> wherein X1 and X2 are independently hydrogen or halogen, which process comprises hydrolysing, using hydrochloric acid, the corresponding ester of formula II,<br><br> ° OR<br><br> ri<br><br> /<br><br> X&gt;s^P-OR<br><br> x2^;p-or<br><br> / V<br><br> (II)<br><br> wherein X1 and X2 are defined above and R is a CM straight or branched chain alkyl group and converting the acid to a-SSlt by reaction.with a base characterised in that the concentration of hydrochloric acid is from 15% to 20% by weight and water is removed azeotropically from the resultant acid using n-butanol prior to the addition of an amine or a base.<br><br> 1 0<br><br> 2. The process as claimed in claim 1 wherein X and X" are both fluorine, chlorine or bromine.<br><br> I n<br><br> 3. The process as claimed in claim 2 wherein X and X" are both chlorine.<br><br> WO 01/21629<br><br> 11<br><br> PCT/GB00/03473<br><br> 4. The process as claimed in claims 1 to 3 wherein the tetraester of formula II is the tetraisopropyl ester.<br><br> 5. The process as claimed in claim 1 wherein the compound of formula II is dichloromethylene bisphosphonate tetraisopropyl ester.<br><br> 6. The process as claimed in any one of claims 1 to 5 wherein the acid product of the hydrolysis is reacted with an organic or inorganic base such as a Cu, straight or branched primary, secondary or tertiary alkylamine, aralkylamine. basic N-containing heterocycle, alkali or alkaline earth metal hydroxide.<br><br> 7. The process as claimed in claim 6 wherein the base is selected from the group comprising C,.4 straight or branched primary, secondary or tertiary alkylamine, aralkyl amine, basic N-containing heterocycle or alkali metal hydroxides.<br><br> 8. The process as claimed in claim 7, wherein the base is selected from the group comprising triethylamine, tri-n-propylamine, diisopropylethylamine, tri-n-butylamine, pyridine, tribenzylamine and sodium-hydroxide.<br><br> 9. The procgss as. claimed in claim 8, wherein the volume of hydrochloric acid used is from about\3 to about 5 volumes..<br><br> 10. The process as claimed in any one of claims 1 to 9 wherein the hydrolysis is carried out at from about 80°C to about 90°C.<br><br> 11. The process as claimed in any one of claims 1 to 10 wherein a vacuum is applied following the addition of n-butanol.<br><br> 12. A salt of substituted or unsubstituted methylene bisphosphonic acid of formula I<br><br> WO 01/21629<br><br> PCT/GB00/03473<br><br> 12<br><br> X<br><br> \ 0H<br><br> P-OH<br><br> x2";p-oh<br><br> 1 2<br><br> wherein X and X are independently hydrogen or halogen.<br><br> 1 ^<br><br> 13. A salt as claimed in claim 12 wherein X and X" are both hydrogen, fluorine, chlorine or bromine.<br><br> 14. A salt as claimed in claim 13 wherein X1 and X" are both chlorine.<br><br> 1 ?<br><br> 15. A salt as claimed in claim 12 wherein one of X and X" is hydrogen and one is chlorine.<br><br> 16. A salt as claimed in any one of claims 12 to 15 wherein the salt is a C]_6 straight or branched primary, secondary or tertiary alkyl amine salt; an aralkyl amine salt, a basic N-containing heterocycle salt, an alkali or alkaline earth metal salt.<br><br> 17. A salt as claimed in claim 16 wherein the salt is a C 1.4 straight or branched primary,<br><br> secondary or tertiary alkylamine salt, an aralkyl amine salt, a basic N-containing heterocycle salt or an alkali metal salt such as sodium or potassium salt,<br><br> 18. A salt as claimed in claim 17 wherein the salt is a triethylamine, tri-n-propylamine, diisopropylethylamine, tri-n-butylamine, pyridine, tribenzylamine or sodium salt.<br><br> 19. A salt as claimed in claim 18 which is selected from dichloromethylene bisphosphonic acid, mono(tri-n-butylamine) salt<br><br> WO
  1. 01/21629<br><br> 13<br><br> PCT/GB00/03473<br><br> dichloromethylene bisphosphonic acid, monopyridine salt dichloromethylene bisphosphonic acid, mono(triethylamine) salt dichloromethylene bisphosphonic acid, mono(diisopropvlethylamine) salt dichloromethylene bisphosphonic acid, mono(tribenzylamine) salt dichloromethylene bisphosphonic acid, mono(tri-n-propylamine) salt dichloromethylene bisphosphonic acid, disodium salt.<br><br> 14<br><br> A process according to claim 1 substantially as herein described or exemplified.<br><br> A salt according to claim 12 substantially as herein described or exemplified.<br><br> </p> </div>
NZ517552A 1999-09-17 2000-09-11 Process for preparing methylene bisphosphonic and salts NZ517552A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE9903345A SE9903345D0 (en) 1999-09-17 1999-09-17 Novel process
PCT/GB2000/003473 WO2001021629A1 (en) 1999-09-17 2000-09-11 Process for preparing methylene bisphosphonic and salts

Publications (1)

Publication Number Publication Date
NZ517552A true NZ517552A (en) 2003-09-26

Family

ID=20417040

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ517552A NZ517552A (en) 1999-09-17 2000-09-11 Process for preparing methylene bisphosphonic and salts

Country Status (24)

Country Link
US (2) US6657076B1 (en)
EP (1) EP1216253B1 (en)
JP (1) JP4881524B2 (en)
KR (1) KR100776105B1 (en)
CN (1) CN1150200C (en)
AR (1) AR029393A1 (en)
AT (1) AT242778T (en)
AU (1) AU771628B2 (en)
BR (1) BR0014057A (en)
CA (1) CA2383829C (en)
CO (1) CO5231228A1 (en)
DE (1) DE60003323T2 (en)
DK (1) DK1216253T3 (en)
ES (1) ES2200921T3 (en)
HK (1) HK1045696B (en)
IL (2) IL148442A (en)
MY (1) MY119965A (en)
NO (1) NO331532B1 (en)
NZ (1) NZ517552A (en)
PT (1) PT1216253E (en)
SE (1) SE9903345D0 (en)
TW (1) TWI274057B (en)
WO (1) WO2001021629A1 (en)
ZA (1) ZA200201661B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903345D0 (en) * 1999-09-17 1999-09-17 Astra Pharma Prod Novel process
JP2009511449A (en) * 2005-10-06 2009-03-19 イナート・ファルマ Phosphorylated antigen salt of organic base and crystallization method thereof
JP5363045B2 (en) * 2008-07-24 2013-12-11 大八化学工業株式会社 Method for producing phosphonic acid
PE20171246A1 (en) 2015-01-14 2017-08-24 Chiesi Farm Spa PHARMACEUTICAL FORMULATIONS THAT INCLUDE HIGH PURITY CANGRELOR AND METHODS FOR THE PREPARATION AND USE OF SAME

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3251907A (en) * 1962-08-23 1966-05-17 Procter & Gamble Method for preparing tetra-secondary alkyl methylenediphosphonates
CA777769A (en) 1963-03-18 1968-02-06 H. Roy Clarence Substituted methylene diphosphonic acid compounds and detergent compositions
JPS54125777A (en) 1978-03-20 1979-09-29 Kao Corp Bleaching composition
IT1201087B (en) * 1982-04-15 1989-01-27 Gentili Ist Spa PHARMACOLOGICALLY ACTIVE BIPPHOSPHONES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
US4478763A (en) * 1982-10-20 1984-10-23 Univ. Of Southern California Process for preparing alpha-fluorinated alkanediphosphonates
JPS61123709A (en) * 1984-11-19 1986-06-11 Nippon Soken Inc Controller for internal-combustion engine provided with exhaust gas particulate emission control function
US4689123A (en) * 1986-12-23 1987-08-25 The Dow Chemical Company Novel tetraphosphonic acid compounds, intermediates and a process for their production
FI83421C (en) * 1989-06-21 1991-07-10 Huhtamaeki Oy FOERFARANDE FOER FRAMSTAELLNING AV FARMAKOLOGISKT ANVAENDBARA METYLENBISFOSFONSYRADERIVAT.
FI83657C (en) * 1989-09-08 1991-08-12 Huhtamaeki Oy Process for the preparation of methylene bisphosphonic acids
FI89366C (en) 1990-12-20 1993-09-27 Leiras Oy Process for the preparation of novel pharmacologically useful methylenebisphosphonic acid derivatives
NZ261159A (en) 1993-02-10 1997-06-24 Astra Pharma Prod Atp analogue and pharmaceutical compositions thereof
EP0742279A1 (en) 1995-05-10 1996-11-13 The Procter & Gamble Company Acidic aqueous liquid compositions
SE9701219D0 (en) 1997-04-04 1997-04-04 Astra Pharma Prod New compounds
FI109088B (en) 1997-09-19 2002-05-31 Leiras Oy Tablet and process for its preparation
SE9903345D0 (en) * 1999-09-17 1999-09-17 Astra Pharma Prod Novel process

Also Published As

Publication number Publication date
CN1150200C (en) 2004-05-19
CO5231228A1 (en) 2002-12-27
AU771628B2 (en) 2004-04-01
AT242778T (en) 2003-06-15
US20040171870A1 (en) 2004-09-02
JP4881524B2 (en) 2012-02-22
KR100776105B1 (en) 2007-11-15
WO2001021629A1 (en) 2001-03-29
BR0014057A (en) 2002-05-21
DE60003323D1 (en) 2003-07-17
IL148442A (en) 2005-08-31
AR029393A1 (en) 2003-06-25
US7288673B2 (en) 2007-10-30
NO20021269D0 (en) 2002-03-14
DE60003323T2 (en) 2004-04-29
EP1216253B1 (en) 2003-06-11
AU7027000A (en) 2001-04-24
ZA200201661B (en) 2003-08-27
HK1045696B (en) 2003-11-21
HK1045696A1 (en) 2002-12-06
CN1371383A (en) 2002-09-25
IL148442D0 (en) 2002-09-12
KR20020029135A (en) 2002-04-17
SE9903345D0 (en) 1999-09-17
CA2383829C (en) 2009-01-20
DK1216253T3 (en) 2003-09-15
EP1216253A1 (en) 2002-06-26
IL168246A (en) 2010-05-17
ES2200921T3 (en) 2004-03-16
US6657076B1 (en) 2003-12-02
PT1216253E (en) 2003-10-31
NO331532B1 (en) 2012-01-23
CA2383829A1 (en) 2001-03-29
MY119965A (en) 2005-08-30
TWI274057B (en) 2007-02-21
NO20021269L (en) 2002-03-14
JP2003509517A (en) 2003-03-11

Similar Documents

Publication Publication Date Title
JP2008517964A (en) Ibandronate manufacturing method
US7288673B2 (en) Salts of substituted methylene bisphosphonic acids
KR20080007347A (en) Generation of phosphorus oxychloride as by-product from phosphorus pentachloride and dmf and its use for chlorination reaction by converting into vilsmeier-haack reagent
US3959361A (en) Process of producing amino methylene phosphonic acids
JP4465153B2 (en) Method for preparing 1-hydroxy-1,1-diphosphonic acid compound
EP0097522A2 (en) Preparation of N-phosphonomethylglycine
AU2002321098B2 (en) Method for producing N-phosphonomethylglycine
EP0693074B1 (en) Process for the manufacture of aminomethanephosphonic acid
EP2144919B1 (en) Multi step synthesis of ibandronate
US6600067B2 (en) Process for preparing ethylenediphosphonic acids
FI69081B (en) Phosphonoformaldehydhydrat foerfarande foer dess framstaellning och dess anvaendning som mellanprodukt vid framstaellning avaekemedel
JP3901321B2 (en) Method for producing riboflavin-5&#39;-phosphate or a sodium salt thereof
RU2041230C1 (en) Method of synthesis of methylenebisphosphonic acids or their salts
SU688504A1 (en) Method of preparing (beta-carboxyethyl)phosphine oxides
EP0451596B1 (en) Phosphonylation process
TWI292763B (en) Salts of substituted or unsubstituted methylene bisphosphonic acid
SU1348341A1 (en) Method of producing salts of 3,5-dialkylpyrocatecholphosphoric acid
KR100193368B1 (en) Method for preparing riboflavin 5&#39;-phosphate salt
KR20120025678A (en) New synthetic method of 9-[2-phosphonomethoxy)ethyl]adenine
GB2202224A (en) Benzodioxole derivative useful as an intermediate

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 11 SEP 2020 BY CPA GLOBAL

Effective date: 20130725

EXPY Patent expired